HOW TO TREAT PATIENTS AFTER SERIOUS ADVERSE EFFECTS CAUSED BY TNF INHIBITORS?

Biological agents are widely used in the treatment of autoimmune rheumatic disorders. We report on serious adverse events during treatment with anti-tumor necrosis factor antibody in two of our patients with juvenile idiopathic arthritis. One patient was treated with a biological agent due to juveni...

Descripción completa

Detalles Bibliográficos
Autores principales: Sršen, Saša, Marušić, Eugenija, Metličić, Vitomir, Stričević, Luka, Frković, Marijan, Jelušić, Marija
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382877/
https://www.ncbi.nlm.nih.gov/pubmed/32724288
http://dx.doi.org/10.20471/acc.2020.59.01.20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382877/
https://www.ncbi.nlm.nih.gov/pubmed/32724288
http://dx.doi.org/10.20471/acc.2020.59.01.20

Ejemplares similares